Abstract: A light emitting display device including a substrate including first and second subpixels, a first insulating layer on the substrate, a first anode including first lower and upper electrodes on the first insulating layer at the first subpixel, a second anode including second lower and upper electrodes spaced from each other by the first insulating layer at the second subpixel, a first electrode pattern at non-emission areas and spaced from the first lower electrode, and a second electrode pattern spaced from the second lower electrode to overlap the first electrode pattern. A first vertical distance from an upper surface of the substrate to an upper surface of the first electrode pattern may be greater than a second vertical distance from the upper surface of the substrate to an upper surface of the first upper electrode.

Abstract: The present invention provides a novel compound having a protein kinase inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof. The compound according to the present invention, stereoisomers thereof or pharmaceutically acceptable salts thereof are effective in preventing or treating protein kinase-related diseases such as cancers, autoimmune diseases, neurological diseases, metabolic diseases, infections or the like by showing a protein kinase inhibitory activity.

Abstract: A system on chip includes a processor and an input and output circuit including a plurality of input and output elements connected to the processor, wherein the plurality of input and output elements includes: a first input and output element spaced apart from the processor by a first distance; and a second input and output element spaced apart from the processor by a second distance, greater than the first distance, and connected to the processor by a first electrical path extending through a first region of the first input and output element, and wherein the first input and output element is connected to the processor by at least one first terminal provided in a second region that is separate from the first region.

Abstract: An organic light-emitting diode display device can include a substrate including a first sub-pixel and a second sub-pixel; an interlayer insulation layer over the substrate and having different heights; and a first light-emitting diode disposed at the first sub-pixel and a second light-emitting diode disposed at the second sub-pixel over the substrate, wherein each of the first light-emitting diode or second light-emitting diode includes a first electrode, a light-emitting layer, and a second electrode, and the light-emitting layer includes a first stack, a charge generation layer, and a second stack, and wherein the second electrode of the first light-emitting diode is electrically connected to the charge generation layer of the first light-emitting diode, and the second electrode of the second light-emitting diode is separated from the charge generation layer of the second light-emitting diode.

Abstract: An organic light-emitting diode display device can include a plurality of sub-pixels disposed on a substrate, at least one transistor disposed at each of the plurality sub-pixels over the substrate, a first insulation layer disposed over the at least one transistor, and a light-emitting diode disposed at each of the plurality of sub-pixels over the first insulation layer. Further, the light-emitting diode includes a first electrode, a light-emitting layer, and a second electrode. Also, each of the plurality of sub-pixels includes a contact area and an emission area, the light-emitting diode is electrically connected to the at least one transistor in the contact area. The first insulation layer includes a recessed portion in the contact area.

Abstract: The present invention relates to a benzamide derivative, a method for preparing same, and a pharmaceutical composition for the prevention or treatment of cancer, containing same as an active ingredient. The benzamide derivative according to an aspect of the present invention can be used in the prevention or treatment of cancer by suppressing EGFR mutation, and, when administered in combination with an EGFR antagonist such as cetuximab, exhibits a significantly synergistic effect on anticancer activity, and thus can be effectively used as an anticancer agent.

Abstract: An organic light emitting diode display device includes a substrate having first and second subpixels; an interlayer insulating layer on the substrate and having a trench between the first and second subpixels; a first electrode in each of the first and second subpixels on the interlayer insulating layer; a bank layer covering an edge portion of the first electrode and exposing a central portion of the first electrode; an emitting layer and a second electrode sequentially disposed on the bank layer and the first electrode exposed through the bank layer; and a passivation layer on the second electrode and wrapping the emitting layer and the second electrode.

Abstract: The present application provides a hetero-cyclic compound capable of significantly enhancing lifetime, efficiency, electrochemical stability and thermal stability of an organic light emitting device, and an organic light emitting device comprising the hetero-cyclic compound in an organic material layer.

Abstract: The present specification relates to a heterocyclic compound represented by Chemical Formula 1, and an organic light emitting device comprising the same.

Abstract: The present invention provides a novel compound having a protein kinase inhibition activity, a stereoisomer thereof or a pharmaceutically acceptable salt thereof. The compound, the stereoisomer thereof or the pharmaceutically acceptable salt thereof according to the present invention show a protein kinase inhibition activity, thus being effective in preventing or treating diseases related to protein kinase, such as cancer, autoimmune disease, neurological disease, metabolic disease, infection or the like.